))
To Get Better Cancer Drugs Faster, Is It Time for an “International FDA"?
Manage episode 425795243 series 3560609
Innhold levert av Jacqueline Stone and OBR Oncology. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Jacqueline Stone and OBR Oncology eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
From ASCO 2024
The time it takes for a novel cancer therapy to go from investigational new drug application to U.S. Food and Drug Administration (FDA) approval is typically longer than a decade. “There has to be a better way,” says Bob T. Li, MD, PhD, MPH, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City and associate professor of medicine at Cornell University in Ithaca, New York.
111 episoder
Del
